Glenn Grossman

Glenn Grossman is an experienced epidemiologist and analytics professional currently serving as an Adjunct Professor of Epidemiology at Rutgers School of Public Health.13 His career spans over 25 years in studying and forecasting disease distribution, determinants, and treatment dynamics globally.2

Professional Experience

Glenn Grossman has held several senior positions in the pharmaceutical and healthcare industries:

• Independent Consultant: Since January 2021, focusing on pandemic epidemiology analytics, insights, and forecasting.1
• Senior Director, Epidemiology & Strategic Forecasting: At Axtria - Ingenious Insights from March 2022 to September 2023.12
• Senior Director Outcomes Research (HEOR): At Novartis from July 2019 to December 2020.1
• Head of Commercial Analytics: At The Medicines Company from July 2019 to March 2020.1
• Global Director of Forecasting, Insights and Analytics: At Sanofi from January 2015 to July 2019.1
• Statistician Lead (Epidemiology Forecasting): At Bristol-Myers Squibb from January 2013 to January 2015.1

Academic Role

As an Adjunct Professor at Rutgers School of Public Health since January 2022, Glenn Grossman teaches:

• Cancer Epidemiology
• Advanced Methods
• Advanced Analytics1

He specializes in epidemiology predictive modeling and advanced methods.2

Expertise

Grossman's extensive experience includes:

• Developing and managing advanced patient analytics
• Generating priority insights for pharmaceutical strategy
• Working with major healthcare datasets from U.S. federal government agencies
• Leading projects with the CDC, Military Health Service, Veterans Health Administration, NIH, and CMS2

His work has contributed to strategy across the pharmaceutical lifecycle, including business development, pipeline management, in-line products, and managed markets.2

Glenn Grossman's LinkedIn profile can be found under the username glenn-grossman-3394036.1